- Home
- ALUB vs TOI Comparison
ALUB vs TOI Comparison
Compare ALUB & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ALUB | TOI |
|---|---|---|
| Founded | N/A | 2007 |
| Country | | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Nursing Services |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 359.7M | 327.6M |
| IPO Year | 2026 | N/A |
Fundamental Metrics
Financial Performance| Metric | ALUB | TOI |
|---|---|---|
| Price | $10.00 | $3.52 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $6.67 |
| AVG Volume (30 Days) | 3.2K | ★ 2.0M |
| Earning Date | N/A | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $27.81 |
| Revenue Next Year | N/A | $25.94 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.91 | $0.88 |
| 52 Week High | $10.10 | $4.88 |
Technical Indicators
Market Signals| Indicator | ALUB | TOI |
|---|---|---|
| Relative Strength Index (RSI) | 45.48 | 67.92 |
| Support Level | $9.98 | $3.35 |
| Resistance Level | $10.10 | $3.58 |
| Average True Range (ATR) | 0.02 | 0.30 |
| MACD | -0.01 | 0.12 |
| Stochastic Oscillator | 0.00 | 80.51 |
Price Performance
Historical ComparisonAbout ALUB Alussa Energy Acquisition Corp. II Class A Ordinary Shares
Alussa Energy Acquisition Corp II is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities.
About TOI The Oncology Institute Inc.
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.